ClassID:

20900

A61K38/08 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Recent Application in this class:
#601
20210388026
2021-12-16

Treatments for Gastrointestinal Disorders

#602
20210388025
2021-12-16

Pharmacokinetics and cholecystokinin-2 receptor (CCK2R) targeting for diagnosis and therapy

#603
20210380640
2021-12-09

SARS-CoV-2 epitope-targeted peptide immunostimulants

#604
20210379141
2021-12-09

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING LUNG DISEASE

#605
20210371532
2021-12-02

Antibodies targeting a complex comprising non-classical HLA-I and neoantigen and their methods of use

#606
20210371478
2021-12-02

GENERATION OF BRAIN AND SPINAL CORD NEURONS, CARDIAC MYOCYTES, AND HEPATOCYTES USING REG PEPTIDES, PEPTIDOMIMETICS, SMALL MOLECULES AND STIMULATORY ANTIBODIES TO REG RECEPTOR

#607
20210369807
2021-12-02

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#608
20210369585
2021-12-02

Peptide exhibiting wrinkle-improving activity and uses thereof

#609
20210361734
2021-11-25

COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY

#610
20210361580
2021-11-25

Storage stable sincalide formulations

#611
20210353712
2021-11-18

METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF

#612
20210346573
2021-11-11

CHONDROINDUCTIVE PEPTIDES AND COMPOSITIONS AND METHODS OF USE THEREOF

#613
20210346505
2021-11-11

Oral formulations of kappa opioid receptor agonists

#614
20210346459
2021-11-11

Application of Dalargin for the prevention of VRIs and prevention of the development of complications during VRIs

#615
20210346458
2021-11-11

COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN

#616
20210338735
2021-11-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#617
20210338734
2021-11-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#618
20210338581
2021-11-04

Liposomal compositions and methods of use

#619
20210332104
2021-10-28

THERAPEUTIC PEPTIDES AND METHODS FOR TREATING AUTOIMMUNE RELATED DISEASE

#620
20210330741
2021-10-28

POLYPEPTIDE THERAPEUTICS AND USES THEREOF

#621
20210330708
2021-10-28

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#622
20210330706
2021-10-28

Children Blood Transfusion and Thymus Hormonal Therapy as Antiviral and Antibacterial Compounds

#623
20210324004
2021-10-21

Peptides for the treatment of covid-19

#624
20210322690
2021-10-21

Intranasal administration

#625
20210322509
2021-10-21

Methods for Reducing Perinatal Morbidity and / or Mortality

#626
20210322508
2021-10-21

PEPTIDES AND COMPOSITIONS FOR TARGETED TREATMENT AND IMAGING

#627
20210322478
2021-10-21

Peptides and combination thereof for use in the immunotherapy against cancers

#628
20210315964
2021-10-14

Compositions and methods for treatment of acute lung injury

#629
20210315941
2021-10-14

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

#630
20210308021
2021-10-07

PEPTIDE NANOPARTICLES AND USES THEREFOR

#631
20210299481
2021-09-30

COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH PERMEABILITY OF INTESTINAL EPITHELIUM

#632
20210299257
2021-09-30

Methods, Systems and Apparatus for Reducing Pathogen Loads in Circulating Body Fluids

#633
20210299209
2021-09-30

SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION

#634
20210299208
2021-09-30

SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION

#635
20210299207
2021-09-30

Systems, methods, and kits for diagnostics and treatment of viral respiratory infection

#636
20210299158
2021-09-30

Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues

#637
20210290743
2021-09-23

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#638
20210290726
2021-09-23

Bioconjugates with chemically modified backbones

#639
20210290724
2021-09-23

Compositions and methods of targeting cancer stem cells

#640
20210285962
2021-09-16

Protein biomarkers for diseases associated with the contact activation system

#641
20210284692
2021-09-16

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#642
20210283276
2021-09-16

Compositions for neuromodulation of mosquito feeding behavior and uses thereof

#643
20210277080
2021-09-09

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#644
20210275761
2021-09-09

Intranasal administration

#645
20210275624
2021-09-09

TREATMENTS FOR IMPROVING OR LESSENING IMPAIRMENT OF MITOCHONDRIAL FUNCTION

#646
20210275600
2021-09-09

Methods for diagnosis and treatment of type 1 diabetes

#647
20210268062
2021-09-02

INFLAMMATORY SKIN DISORDER TREATMENT

#648
20210261612
2021-08-26

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

#649
20210260154
2021-08-26

METHODS FOR ATTENUATING RELEASE OF INFLAMMATORY MEDIATORS AND PEPTIDES USEFUL THEREIN

#650
20210260150
2021-08-26

Dry powder formulation of caveolin-1 peptides and methods of use thereof

#651
20210260149
2021-08-26

Anti-neurodegenerative therapeutic, method of manufacture, and use

#652
20210260120
2021-08-26

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#653
20210253636
2021-08-19

Tandem repeat cancer-targeting peptides for molecular conjugation or engineering and uses thereof in cancer theranostics

#654
20210252158
2021-08-19

Conjugates of a glycoprotein or a glycan with a toxic payload

#655
20210252113
2021-08-19

PIC1 inhibition of myeloperoxidase oxidative activity in an animal model

#656
20210252102
2021-08-19

METHODS FOR ENHANCING IMMUNOTHERAPY IN THE TREATMENT OF CANCER

#657
20210244788
2021-08-12

ORAL PEPTIDE ANTAGONISTS OF MULTIPLE CHEMOKINE RECEPTORS FOR REVERSING LOSS OF SYNAPSES AND DENDRITIC SPINES

#658
20210244787
2021-08-12

Nutritional Supplements Containing A Peptide Component And Uses Thereof

#659
20210244765
2021-08-12

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#660
20210236638
2021-08-05

COMBINATION THERAPIES FOR TREATMENT OF CANCER

#661
20210236586
2021-08-05

Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors

#662
20210230240
2021-07-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#663
20210228733
2021-07-29

Methods and compositions for theranostic nanoparticles

#664
20210228681
2021-07-29

Compositions and methods for treating glioblastoma

#665
20210228677
2021-07-29

PHARMACEUTICAL COMPOSITION AND A METHOD FOR ITS MANUFACTURE

#666
20210221845
2021-07-22

Arid5a peptide inhibitors

#667
20210220288
2021-07-22

NATURAL NANOPARTICLE-MEDICINE COMPOSITION FOR TREATING ALZHEIMER'S DISEASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#668
20210213115
2021-07-15

PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS

#669
20210213064
2021-07-15

Peptides and combination of peptides of non- canonical origin for use in immunotherapy against different types of cancers

#670
20210205405
2021-07-08

Compositions and methods for invasive and non-invasive procedural skincare

#671
20210205200
2021-07-08

Peptide for preventing skin damage caused by air pollutants and for anti-aging, and use thereof

#672
20210198316
2021-07-01

MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS

#673
20210196807
2021-07-01

Cancer-specific T-cell receptors

#674
20210196784
2021-07-01

PEPTIDES FOR USE IN PROMOTING TRANSPORT OF GLUCOSE

#675
20210196783
2021-07-01

NEW PHARMACEUTICAL USE

#676
20210190791
2021-06-24

HIF-1 and HIF-2 inhibitors

#677
20210188944
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#678
20210188943
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

#679
20210188911
2021-06-24

PEPTIDES OF USE IN THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA

#680
20210187057
2021-06-24

Methods and compositions for use of a chemokine receptor antagonist peptide to treat addiction, substance abuse disorders or symptoms thereof

#681
20210179691
2021-06-17

Peptides and combination of peptides for use in immunotherapy against various tumors

#682
20210177917
2021-06-17

MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY

#683
20210169999
2021-06-10

ENOLASE 1 (ENO1) COMPOSITIONS AND USES THEREOF

#684
20210169968
2021-06-10

COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY

#685
20210169967
2021-06-10

Antimicrobial peptide stimulating cleansing composition

#686
20210169966
2021-06-10

Peptidyl inhibitors of calcineurin-NFAT interaction

#687
20210169965
2021-06-10

SUSTAINED RELEASE PEPTIDE FORMULATIONS

#688
20210163557
2021-06-03

METHODS AND COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISORDERS AND ALZHEIMER'S DISEASE AND IMPROVING NORMAL MEMORY

#689
20210161994
2021-06-03

IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF

#690
20210161993
2021-06-03

Method for accelerated healing of burn wounds

#691
20210161992
2021-06-03

Phosphorylcholine conjugates and uses thereof

#692
20210161810
2021-06-03

Pharmaceutical Compositions Including Low Dosages of Desmopressin

#693
20210154312
2021-05-27

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#694
20210154311
2021-05-27

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#695
20210154306
2021-05-27

Degradable thiol-ene polymers and methods of making thereof

#696
20210154260
2021-05-27

FORMULATIONS FOR A TIGHT JUNCTION EFFECTOR

#697
20210145921
2021-05-20

COMPOSITION COMPRISING VEGF ANTAGONISTS AND A CATIONIC PEPTIDE AND USES THEREOF

#698
20210145888
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#699
20210145887
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#700
20210145886
2021-05-20

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#701
20210145819
2021-05-20

Topical formulations comprising montelukast and combinations with mussel adhesive proteins

#702
20210145749
2021-05-20

NOVEL TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES BIO MODULATED CERAMICS

#703
20210138025
2021-05-13

CATIONIC PEPTIDES WITH IMMUNOMODULATORY AND/OR ANTI-BIOFILM ACTIVITIES

#704
20210138024
2021-05-13

Manufacture of degarelix

#705
20210137986
2021-05-13

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#706
20210137985
2021-05-13

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#707
20210137969
2021-05-13

COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CEREBRAL ATROPHY

#708
20210137811
2021-05-13

TRPV3 agonists for the treatment of skin conditions

#709
20210130403
2021-05-06

Inhibitors of metastasis

#710
20210128709
2021-05-06

COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE

#711
20210128688
2021-05-06

Q-peptide hydrogel promotes immune modulation and macrophage differentiation

#712
20210128673
2021-05-06

Method of treating prostate cancer with GnRH antagonist

#713
20210128671
2021-05-06

Adiponectin peptidomimetics for treating ocular disorders

#714
20210128670
2021-05-06

Dosing regimens for echinocandin class compounds

#715
20210128669
2021-05-06

Linear lipopeptide paenipeptins and methods of using the same

#716
20210128650
2021-05-06

Antiviral methods and compositions comprising probiotic bacterial molecules

#717
20210121517
2021-04-29

STABLE PARENTERAL DOSAGE FORM OF CETRORELIX ACETATE

#718
20210115445
2021-04-22

CHANNEL MODULATORS

#719
20210113650
2021-04-22

NANOMOLECULES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES

#720
20210113619
2021-04-22

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#721
20210113521
2021-04-22

Methods of treating Prader-Willi syndrome

#722
20210109112
2021-04-15

Method of treating and prognosing scoliotic patient subgroups

#723
20210107868
2021-04-15

DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS

#724
20210106647
2021-04-15

CEACAM based antibacterial agents

#725
20210100907
2021-04-08

Drug delivery systems comprising a neurotrophic agent, an apoptosis signaling fragment inhibitor (FAS) or FAS ligand (FASL) inhibitor, a tumor necrosis factor-alpha (TNF-alpha) or TNF receptor inhibitor, a mitochondrial peptide, an oligonucleotide, a chemokine inhibitor, or a cysteine-aspartic protease inhibitor

#726
20210100869
2021-04-08

COMPOSITIONS AND METHODS OF USING SAME FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

#727
20210100868
2021-04-08

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING GASTROINTESTINAL DAMAGE ASSOCIATED WITH NSAID THERAPY

#728
20210100845
2021-04-08

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#729
20210094992
2021-04-01

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#730
20210093689
2021-04-01

Sincalide Formulations

#731
20210093572
2021-04-01

Method for preparing biodegradable microspheres using stabilized single-phase mixed solution

#732
20210087244
2021-03-25

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

#733
20210087243
2021-03-25

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

#734
20210085767
2021-03-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS

#735
20210085751
2021-03-25

NOVEL COMPOSITION

#736
20210085750
2021-03-25

Phage-peptide constructs for stimulating an immune response against CD47

#737
20210085749
2021-03-25

Therapeutic and Neuroprotective Peptides

#738
20210085748
2021-03-25

Implantable medical device having a negatively-charged and antimicrobial surface

#739
20210077629
2021-03-18

IMPROVED PEPTIDE PHARMACEUTICALS

#740
20210077569
2021-03-18

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

#741
20210077566
2021-03-18

Peptides Having Anti-Inflammatory Properties

#742
20210077565
2021-03-18

Method of treating a philadelphia chromosome-positive tumor

#743
20210077564
2021-03-18

Manufacture of Degarelix

#744
20210077563
2021-03-18

Means and methods for treating bacterial infections

#745
20210077540
2021-03-18

BIOACTIVE GREEN-LIPPED MUSSEL EXTRACTS AND USES THEREOF

#746
20210070807
2021-03-11

Compositions and methods for treating diseases by inhibiting exosome release

#747
20210069289
2021-03-11

Stemness-suppressing composition comprising OCT4 function-inhibiting peptide

#748
20210069286
2021-03-11

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HYPERGLYCEMIA, INSULIN RESISTANCE, AND ASSOCIATED ORGAN DAMAGE

#749
20210069285
2021-03-11

Compositions and methods of treating cancer with glycomimetic peptides

#750
20210069284
2021-03-11

Phosphorylcholine conjugates and uses thereof

#751
20210069251
2021-03-11

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#752
20210061852
2021-03-04

Method of treating melanocortin-4 receptor-associated disorders in heterozygous carriers

#753
20210060165
2021-03-04

Light-Controlled Antibacterial Agent Composed of Linear Cationic Oligopeptide and Multi-arm B-Cyclodextrin

#754
20210060131
2021-03-04

Intracellular IL-1 alpha peptide methods and compositions

#755
20210060118
2021-03-04

THERAPEUTIC HOMODIMER AND USES THEREOF

#756
20210060117
2021-03-04

ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION

#757
20210060116
2021-03-04

Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

#758
20210060078
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#759
20210060077
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#760
20210060074
2021-03-04

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#761
20210054042
2021-02-25

Affinity ligands for antibody Fc region

#762
20210054026
2021-02-25

Inhibitors of β integrin-G protein α subunit binding interactions

#763
20210052691
2021-02-25

Method of treating diseases

#764
20210052654
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#765
20210052653
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#766
20210052652
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#767
20210052651
2021-02-25

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#768
20210047369
2021-02-18

Methods for reducing CD36 expression

#769
20210046153
2021-02-18

OCA-B peptide conjugates and methods of treatment

#770
20210046148
2021-02-18

Methods for Increasing the Selective Efficacy of Gene Therapy Using CAR Peptide and Heparan-Sulfate Mediated Macropinocytosis

#771
20210046147
2021-02-18

COMBINATORIAL THERAPIES FOR THE TREATMENT OF NEOPLASIAS USING THE OPIOID GROWTH FACTOR RECEPTOR

#772
20210046114
2021-02-18

HPV IMMUNOTHERAPY

#773
20210041455
2021-02-11

Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same

#774
20210038737
2021-02-11

Cyclic peptidyl inhibitors of CAL-PDZ binding domain

#775
20210038729
2021-02-11

Polypeptides having anti-senescent effects and uses thereof

#776
20210038679
2021-02-11

Compositions and methods for treating vaginal dryness

#777
20210038678
2021-02-11

Compositions comprising cyclic peptides derived from an A-beta peptide

#778
20210038677
2021-02-11

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#779
20210030814
2021-02-04

Compositions and methods for treating or preventing intestinal paracellular permeability

#780
20210024599
2021-01-28

MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE

#781
20210024595
2021-01-28

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

#782
20210023235
2021-01-28

Block copolymers

#783
20210023171
2021-01-28

Peptides and related compositions and methods

#784
20210023164
2021-01-28

Treatment of inflammation

#785
20210023163
2021-01-28

ACTIVATION AND EXPANSION OF NKG2C+ NK CELLS

#786
20210023162
2021-01-28

Bacterial-binding peptides for treatment of infectious diseases and related inflammatory processes

#787
20210023113
2021-01-28

CONJUGATE OF CYTOTOXIC DRUG AND PRODRUG FORM OF SAID CONJUGATE

#788
20210017240
2021-01-21

Sunflower seed protein-derived peptides

#789
20210015944
2021-01-21

Targeted Doxorubicin-Gold Nanocojugates for Tumor Therapy

#790
20210015890
2021-01-21

Composition and methods for promoting and treating chronic wound healing

#791
20210015887
2021-01-21

METHODS FOR REDUCING OXIDATIVE DAMAGE

#792
20210009682
2021-01-14

REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS

#793
20210009636
2021-01-14

Arid5a peptide inhibitors

#794
20210008173
2021-01-14

ENDOSTATIN PEPTIDES FOR THE TREATMENT OF TUMORS, FIBROSIS AND ACUTE LUNG INJURY

#795
20210008162
2021-01-14

Peptides and methods for treating disease

#796
20210008151
2021-01-14

Formulations containing a somatostatin receptor agonist

#797
20210002328
2021-01-07

Peptide therapies for reduction of macular thickening

#798
20210000964
2021-01-07

Fatty acids and their use in conjugation to biomolecules

#799
20210000914
2021-01-07

Antimicrobial compositions and methods of use thereof

#800
20210000912
2021-01-07

Compositions And Methods For Prophylaxis Or Treatment Of Pain

#801
20210000910
2021-01-07

TOPICAL COMPOSITIONS

#802
20210000909
2021-01-07

Peptide composition for treating excitatory neurotoxicity related injuries

#803
20210000767
2021-01-07

Muscular atrophy-inducing agent using hypometabolism-inducing substance T1AM, and use thereof in treating muscular hypertrophy

#804
20200407398
2020-12-31

Short Proline-Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug-and Extensively Drug-Resistant Pseudomonas Aeruginosa

#805
20200405802
2020-12-31

Multi-functional peptides and use thereof

#806
20200399333
2020-12-24

Histatins and method of use thereof

#807
20200397906
2020-12-24

Pharmaceutical compositions and related methods of delivery

#808
20200397850
2020-12-24

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY

#809
20200392183
2020-12-17

Immunogenic WT-1 peptides and methods of use thereof

#810
20200392181
2020-12-17

PEPTIDE COMPOSITIONS AND RELATED METHODS

#811
20200390850
2020-12-17

PEPTIDES AND USES THEREOF

#812
20200390848
2020-12-17

Methods of treating wounds using cathepsin K inhibitors

#813
20200390847
2020-12-17

Method of treating diseases

#814
20200384067
2020-12-10

Treatment of cancer

#815
20200384064
2020-12-10

COMPOSITIONS AND METHODS USING HIGH PROTEIN FOR INDUCTION OF AUTOPHAGY

#816
20200376074
2020-12-03

COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES

#817
20200375863
2020-12-03

Applications and formulations of optimized, modified human embryonic fertility culture media with biguanides and/or functional equivalents

#818
20200369728
2020-11-26

PEPTIDOMIMETIC MACROCYCLES AND USES THEREOF

#819
20200369723
2020-11-26

LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT

#820
20200368322
2020-11-26

METHODS OF IDENTIFYING AND USING AGENTS FOR TREATING DISEASES ASSOCIATED WITH INTESTINAL BARRIER DYSFUNCTION

#821
20200368315
2020-11-26

ANTIMICROBIAL PEPTIDES AND ADMIXTURES THEREOF SHOWING ANTIMICROBIAL ACTIVITY AGAINST GRAM-NEGATIVE PATHOGENS

#822
20200368314
2020-11-26

PEPTIDES FOR TREATMENT AND PREVENTION OF NONALCOHOLIC FATTY LIVER DISEASE

#823
20200368230
2020-11-26

Compositions and methods to protect mammalian tissue against cold and other metabolic stresses

#824
20200360433
2020-11-19

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#825
20200354407
2020-11-12

Peptide inhibitors of insulin-degrading enzyme

#826
20200354402
2020-11-12

PEPTIDE COMPOSITIONS AND RELATED METHODS

#827
20200353086
2020-11-12

CONTROLLED-RELEASE FORMULATIONS

#828
20200353076
2020-11-12

Anti-folate receptor alpha antibody conjugated with hemiasterlins

#829
20200352972
2020-11-12

ALDOXORUBICIN COMBINATION TREATMENTS AND METHODS

#830
20200345842
2020-11-05

Compositions for stimulation of mammalian innate immune resistance to pathogens

#831
20200345821
2020-11-05

Methods and compositions for reducing growth, migration and invasiveness of brain cancer stem cells and improving survival of patients with brain tumors

#832
20200345805
2020-11-05

COMPOSITIONS AND METHODS USEABLE FOR TREATMENT OF DRY EYE

#833
20200345804
2020-11-05

Agents targeting inhibitor of apoptosis proteins

#834
20200345662
2020-11-05

MUSCULAR ATROPHY-INDUCING AGENT USING HYPOMETABOLISM-INDUCING SUBSTANCE T1AM, AND USE THEREOF IN TREATING MUSCULAR HYPERTROPHY

#835
20200339997
2020-10-29

Treatment for skeletal diseases caused by intracellular protein trafficking defects

#836
20200339646
2020-10-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#837
20200339645
2020-10-29

B*44 restricted peptides for use in immunotherapy against cancers and related methods

#838
20200338154
2020-10-29

Compositions and methods for invasive and non-invasive procedural skincare

#839
20200338112
2020-10-29

METHODS AND MATERIALS FOR TREATING CANCER

#840
20200331965
2020-10-22

Compositions and methods for managing respiratory conditions

#841
20200330546
2020-10-22

Hangover alleviating composition containing conjugate of sesamol and peptide as active ingredient

#842
20200325206
2020-10-15

Peptides and combination of peptides for use in immunotherapy against various tumors

#843
20200325203
2020-10-15

Synthetic somatostatin receptor ligands

#844
20200325173
2020-10-15

Drug Delivery Enhancement Agents

#845
20200323973
2020-10-15

Epitope-targeted peptide immunostimulants

#846
20200323967
2020-10-15

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#847
20200323953
2020-10-15

Immunosuppressive agents and their use in therapy

#848
20200323947
2020-10-15

Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof

#849
20200323946
2020-10-15

Peptides and analogs for use in the treatment of oral mucositis

#850
20200323919
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#851
20200323918
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#852
20200323916
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#853
20200323915
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#854
20200323914
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#855
20200323913
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#856
20200323911
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#857
20200323910
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#858
20200323909
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#859
20200323907
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#860
20200323906
2020-10-15

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#861
20200316182
2020-10-08

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#862
20200316171
2020-10-08

Methods and compositions for treatment of Gaucher Disease via modulation of C5a receptor

#863
20200316161
2020-10-08

Preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases

#864
20200316073
2020-10-08

Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection

#865
20200308250
2020-10-01

Peptides and combination of peptides for use in immunotherapy against various tumors

#866
20200308236
2020-10-01

Stapled intracellular-targeting antimicrobial peptides to treat infection

#867
20200306338
2020-10-01

Antiviral peptides for treatment of the middle east respiratory syndrome

#868
20200306337
2020-10-01

Bioactive Metabolities Encoded by the Human Microbiome Using Primary Sequence Alone

#869
20200306311
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#870
20200306308
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#871
20200306305
2020-10-01

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#872
20200299348
2020-09-24

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

#873
20200297795
2020-09-24

Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction

#874
20200297772
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#875
20200297771
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#876
20200297770
2020-09-24

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#877
20200297633
2020-09-24

Peptide-targeted liposomal delivery for treatment, diagnosis, and imaging of diseases and disorders

#878
20200291488
2020-09-17

NMR METHODS AND SYSTEMS FOR THE RAPID DETECTION OF CANDIDA SPECIES

#879
20200289667
2020-09-17

Targeting Macrophages to Modulate Electrical Conduction in the Heart

#880
20200289664
2020-09-17

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CD137+ CELLS

#881
20200289653
2020-09-17

IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE

#882
20200289652
2020-09-17

Drug delivery system containing phospholipid and cholesterol

#883
20200289616
2020-09-17

Human cancer cell metastasis inhibitory agent and human cancer cell determination agent

#884
20200289606
2020-09-17

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS

#885
20200283479
2020-09-10

Treatments for Gastrointestinal Disorders

#886
20200282007
2020-09-10

ANTI-NEURODEGENERATIVE THERAPEUTIC, METHOD OF MANUFACTURE, AND USE

#887
20200282006
2020-09-10

Methods and treatments using toll-like receptor agonists to mitigate hematopoietic myeloid loss, increase gastrointestinal recovery and reduce tumor growth

#888
20200276291
2020-09-03

Immunotherapeutic method for treating lung cancer by administering a polypeptide comprising an epitope of hZP3

#889
20200276262
2020-09-03

Peptides for use in the treatment of viral infections

#890
20200276260
2020-09-03

Use of peptides as therapeutic agent for autoimmune diseases and bone diseases

#891
20200271651
2020-08-27

Methods, compositions, and kits for detection of aspergillosis

#892
20200270323
2020-08-27

Interleukin 15 fusion protein for tumor targeting therapy

#893
20200268914
2020-08-27

Positron emitting radionuclide labeled peptides for human uPAR PET imaging

#894
20200268863
2020-08-27

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#895
20200268832
2020-08-27

COMPOSITIONS FOR DELIVERY TO AND TREATMENT OF ATHEROSCLEROTIC PLAQUES

#896
20200268831
2020-08-27

METHODS FOR ENHANCING IMMUNOTHERAPY IN THE TREATMENT OF CANCER

#897
20200268830
2020-08-27

Antimicrobial compounds from the genus

#898
20200268800
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#899
20200268799
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers

#900
20200268798
2020-08-27

Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers